We are live on
!
Find out more
PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
1-Year Est. Return
55.92%
This Fund
S&P 500
This Quarter
Est. Return
+14.72%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$76.1M
AUM Growth
+$12.2M
(+19%)
Cap. Flow
+$765K
Cap. Flow
% of AUM
1%
Top 10 Holdings %
Top 10 Hldgs %
28.24%
Holding
127
New
34
Increased
22
Reduced
26
Closed
28
Top Buys
| 1 |
Liberty Global Class A
LBTYA
|
+$2.29M |
| 2 |
Marvell Technology
MRVL
|
+$2.07M |
| 3 |
CSC
Computer Sciences
CSC
|
+$1.97M |
| 4 |
Universal Health Services
UHS
|
+$1.75M |
| 5 |
Alibaba
BABA
|
+$1.73M |
Top Sells
| 1 |
Range Resources
RRC
|
+$1.82M |
| 2 |
Cigna
CI
|
+$1.7M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.34M |
| 4 |
Salesforce
CRM
|
+$1.33M |
| 5 |
Biogen
BIIB
|
+$1.29M |
Sector Composition
| 1 | Healthcare | 41.37% |
| 2 | Technology | 11.69% |
| 3 | Communication Services | 6.82% |
| 4 | Energy | 5.01% |
| 5 | Consumer Discretionary | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Marvell Technology
MRVL
$200B
| $2.71M | 3.56% |
177,687
+134,466
| +311% | +$2.07M |
|
|
2
Liberty Global Class A
LBTYA
$3.63B
| $2.32M | 3.05% |
+64,720
| New | +$2.29M |
|
3
Jazz Pharmaceuticals
JAZZ
$15B
| $2.3M | 3.02% |
15,857
-2,489
| -14% | -$324K |
|
|
4
Biogen
BIIB
$28.3B
| $2.29M | 3% |
8,363
-4,570
| -35% | -$1.29M |
|
|
WFT
5
DELISTED
Weatherford International plc
WFT
| $2.13M | 2.8% |
320,408
+153,850
| +92% | +$902K |
|
|
CSC
6
DELISTED
Computer Sciences
CSC
| $2.05M | 2.69% |
+29,718
| New | +$1.97M |
|
7
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.93M | 2.53% |
21,964
-2,510
| -10% | -$223K |
|
8
Humana
HUM
$48.8B
| $1.92M | 2.52% |
9,315
+487
| +6% | +$101K |
|
|
MDCO
9
DELISTED
Medicines Co
MDCO
| $1.89M | 2.49% |
38,703
-22,851
| -37% | -$1.04M |
|
|
10
Universal Health Services
UHS
$8.73B
| $1.85M | 2.43% |
+14,847
| New | +$1.75M |
|
|
11
Alibaba
BABA
$269B
| $1.83M | 2.4% |
+16,967
| New | +$1.73M |
|
12
Elevance Health
ELV
$92.7B
| $1.76M | 2.31% |
10,637
-2,825
| -21% | -$449K |
|
13
Starbucks
SBUX
$121B
| $1.62M | 2.13% |
+27,820
| New | +$1.57M |
|
14
Pacira BioSciences
PCRX
$984M
| $1.56M | 2.05% |
34,213
+7,523
| +28% | +$325K |
|
15
Baxter International
BAX
$11.3B
| $1.46M | 1.91% |
+28,085
| New | +$1.38M |
|
16
GoDaddy
GDDY
$12.1B
| $1.41M | 1.86% |
37,287
+31,225
| +515% | +$1.13M |
|
|
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.39M | 1.83% |
21,837
-3,772
| -15% | -$229K |
|
|
PTLA
18
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.39M | 1.82% |
35,362
+20,890
| +144% | +$665K |
|
|
SLCA
19
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.36M | 1.78% |
28,304
+10,203
| +56% | +$546K |
|
20
UnitedHealth
UNH
$386B
| $1.24M | 1.63% |
7,573
-5,472
| -42% | -$896K |
|
|
AERI
21
DELISTED
Aerie Pharmaceuticals
AERI
| $1.24M | 1.63% |
27,289
-4,557
| -14% | -$203K |
|
22
Eli Lilly
LLY
$1.03T
| $1.17M | 1.54% |
+13,895
| New | +$1.11M |
|
|
TFCFA
23
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $1.13M | 1.48% |
+34,857
| New | +$1.07M |
|
|
KITE
24
DELISTED
Kite Pharma, Inc.
KITE
| $1.06M | 1.39% |
13,513
-3,150
| -19% | -$195K |
|
|
25
Cigna
CI
$80.2B
| $1.04M | 1.37% |
7,119
-11,511
| -62% | -$1.7M |
|
Similar funds
SWM
EAM
BO
ACM
SL
DII
FIM
EM